CIK 0001944885
- Non-accelerated filer
- Emerging growth company
Apollomics Inc.
Sign in to watch- Ticker
- APLM
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- Cayman Islands
- Entity type
- Other
- Phone
- +1 650-209-4055
- Business address
- 668 ARROW GRAND CIR, SUITE 206, COVINA, CA, 91772
Securities
- APLM Class A Ordinary Shares Nasdaq
- APLMW Warrant Nasdaq
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-09-15 | Chen Hung-Wen Chief Executive Officer | Exercise or conversion | +5,000 | 423,334 | ||
| 2026-09-15 | Chen Hung-Wen Chief Executive Officer | Exercise or conversion · Restricted Stock Units | −5,000 | 5,000 | ||
| 2026-09-14 | Chen Hung-Wen Chief Executive Officer | Grant or award · Stock Option (Right to Buy) | +8,000 | 8,000 | ||
| 2026-08-14 | Chen Hung-Wen Chief Executive Officer | Purchase | +166,667 | $12.00 | $2.0M | 315,001 |
| 2026-08-14 | Chen Hung-Wen Chief Executive Officer | Purchase | +103,333 | $15.00 | $1.5M | 418,334 |
| 2026-08-14 | Chen Hung-Wen Chief Executive Officer | Purchase | +266,667 | $15.00 | $4.0M | 1,029,695 |
| 2026-06-15 | Chen Hung-Wen Chief Executive Officer | Exercise or conversion | +5,000 | 148,334 | ||
| 2026-06-15 | Chen Hung-Wen Chief Executive Officer | Exercise or conversion · Restricted Stock Units | −5,000 | 5,000 |
Page 1 of 1 · 8 trades